Steven Zelenkofske
Net worth: 8 908 $ as of 30/06/2026
Net worth: 8 908 $ as of 30/06/2026
Steven L.
Zelenkofske currently serves as Director & Chief Strategy Officer at DiNAQOR AG since 2023.
He is also an Associate Professor at Philadelphia College of Osteopathic Medicine and Hershey Medical Center.
Former positions include Independent Director at Cadrenal Therapeutics, Inc. from 2023 to 2026, Chief Medical Officer at SwanBio Therapeutics, Inc. from 2020 to 2022, Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. from 2018 to 2020, Chief Medical Officer at uniQure NV from 2017 to 2018, Chief Medical Officer at Regado Biosciences, Inc. from 2009 to 2014, VP-Cardiovascular & Thrombosis Medical Unit at Sanofi-Aventis Pharmaceuticals from 2007 to 2009, Chief Patient Safety Officer at Cardiac Rhythm Management from 2006 to 2007, Senior Director at Novartis Pharmaceuticals Corp.
from 2002 to 2006, and Clinical Director at The Heart Care Group.
Education includes undergraduate and graduate degrees from Emory University and a doctorate from Philadelphia College of Osteopathic Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/07/2025 | 2,667 ( 0.09% ) | 8 908 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
Philadelphia College of Osteopathic Medicine
Philadelphia College of Osteopathic Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Hershey Medical Center
Hershey Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
DiNAQOR AG
DiNAQOR AG BiotechnologyHealth Technology Develops gene therapy solutions | Director/Board Member | 01/05/2020 |
| Companies | Position | End |
|---|---|---|
| CADRENAL THERAPEUTICS, INC. | Director/Board Member | 30/06/2026 |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Chief Tech/Sci/R&D Officer | 01/09/2022 |
| ACHILLION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 01/08/2018 |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Chief Tech/Sci/R&D Officer | 01/11/2014 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Emory University
Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Cardiac Rhythm Management
Cardiac Rhythm Management Medical SpecialtiesHealth Technology Manufactures implantable devices to treat arrhythmias | Health Technology |
Philadelphia College of Osteopathic Medicine
Philadelphia College of Osteopathic Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Pharmaceuticals | |
The Heart Care Group
The Heart Care Group Medical/Nursing ServicesHealth Services Provides cardiovascular care services | Health Services |
Hershey Medical Center
Hershey Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Health Technology |
DiNAQOR AG
DiNAQOR AG BiotechnologyHealth Technology Develops gene therapy solutions | Health Technology |
Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
Select your edition
All financial news and data tailored to specific country editions